ActoFactor™ Recombinant Human TNF-Related Weak Inducer of Apoptosis Receptor

CSC-CTK0338

TWEAKR belongs to the TNF family of transmembrane proteins and contains a cytoplasmic death domain which can activated the cells apoptotic machinery. It is expressed in the spleen, thymus, peripheral blood lymphocytes, colon, and small intestine. Signal transduction by TWEAKR can be activated by either the membrane anchored or the soluble TWEAK. Recombinant soluble TWEAKR is a 53 amino acid polypeptide (5.6 kDa) comprising the entire extracellular domain of the full length TWEAKR protein.

Human

Human TNFSF12 expressed in E.coli

5.6 kDa

CAT# CSC-CTK0338-25 (25 μg); CAT# CSC-CTK0338-125 (125 μg)

E.coli

Greater than 98% as determined by SDS-PAGE and HPLC analysis.

Determined by its ability to inhibit TWEAK-induced weak cell death of HT29 cells. The expected ED50 for this effect is 1.0-3.0 μg/ml.

Less than 1 EU/μg.

Lyophilized from a sterile-filtered solution.

Please centrifuge product briefly before opening the vial. Reconstitute in sterile, ultra-pure water to a concentration of 0.1-1.0 mg/ml. This solution can be diluted into other aqueous buffers and stored at -20°C for future use.

The lyophilized powder, though stable at room temperature for up to 3 weeks, is best stored desiccated at -20°C. Reconstituted TWEAK Receptor should be used immediately or stored in undiluted working aliquots at -20°C. Avoid repeated freeze / thaw cycles.

If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.